Regen BioPharma Inc (RGBP)

[Namaste Charting]

Only around 0.07 to 0.1. I personally think that's a good starting point but if any of the 2 ip's we licenced gets to markets they can bring in billions a year & there for give $rbgp 5 to 10% of that. With no over-head expenses either. Bios can get 20 to 30 times easy on pe ratio...so let's say we receive 100 million yearly for sakes of just getting a rough estimate and the lowest of pe of 20x...that's 2 billion market cap. Also may be very low. They have more ip and hear their very excited about the new patent filed in March. It's all here say till we know more but 300 to 400 seems like a good starting point & as he said re-vist as things progress.